
Wellcome Photography Prize 2025: Winning Images Reveal Powerful Stories of Science and Health
A Thousand Cuts, Sujata Setia, 2023, Urban Travel, Mithail Afrige Chowdhury, 2023, Cholesterol in the Liver, 2022, Steve Gschmeissner
Click Here to download press images and captions
LONDON, July 25, 2025 (GLOBE NEWSWIRE) — Wellcome's 2025 Photography Prize celebrates three image makers whose work reveals the human stories behind science and health. UK-based artist Sujata Setia, Bangladeshi documentary and street photographer Mithail Afrige Chowdhury, and UK-based electron microscopy specialist and science photographer Steve Gschmeissner have each been awarded a £10,000 prize for powerful images that reflect how science and health shape people's lives in complex and deeply personal ways, from the from the hidden toll of domestic abuse to the everyday realities of climate migration, to the microscopic processes that underpin heart disease.
Now in its 28th year, the Wellcome Photography Prize celebrates compelling imagery at the intersection of science, health and human experience. From documentary photography to microscopy and medical imaging, it highlights diverse perspectives on global health and the vital role of visual storytelling in creating a healthier future.
The top 25 entries are now on display in the Wellcome Photography Prize 2025 exhibition, which is free and open to the public at the Francis Crick Institute in London, running until 18 October 2025. Each of the finalists has received a £1,000 prize, with a total of £52,000 awarded across the competition.
Lara Clements, Associate Director, Engagement, Wellcome, says, ' The Wellcome Photography Prize offers image-makers a platform to showcase the impact of science and health on lives around the world. This year's winning works stood out not only for their technical accomplishment, but for the care and collaboration behind them. Sujata Setia's portraits raised powerful questions around dignity, confidentiality and sensitivity. Mithail Afrige Chowdhury's image exemplified the value of being embedded in the community and explored themes of adaptation, illusion and fantasy in a compelling way. Steve Gschmeissner's biomedical image impressed us with its precision and raised important questions about how scientific imagery is shared and understood by the public. We hope audiences will find the winners' work moving, educational and inspiring, and enjoy the full exhibition at the Francis Crick Institute.'
The Winners
In the Storytelling Series category, Sujata Setia was recognised for A Thousand Cuts , a deeply collaborative portrait project developed with survivors of domestic abuse within South Asian communities. Each image is a composite of personal testimony, visual symbolism, and traditional craft. Setia worked with the women and with the charity SHEWISE to create portraits that protected anonymity without erasing identity, applying the Indian paper-cutting technique sanjhi to overlay each photograph. The results are intimate, powerful reflections on generational trauma, silence, survival, and the politics of representation. From the account of a woman forced into marriage twice by her father and left with lasting PTSD, to a mother determined to break the cycle of violence for her daughter, the series captures how abuse can become ingrained and normalised, and how art can offer a means of reclaiming narrative.
Sujata Setia says, ' This is a monumental recognition. A Thousand Cuts being selected for Wellcome Photography Prize affirms that health cannot be separated from the histories that shape it. And that domestic abuse is never a singular event; it leaves a direct, trans-generational imprint on health. As a child who grew up in a home where violence was a daily occurrence, I carry that trauma like another limb. This recognition validates not just my story, but the invisible, intangible, yet deeply scarring legacy of gender-based abuse. Domestic abuse is one of the most widespread global crimes; and yet remains among the least publicly acknowledged health crises. I hope this moment becomes a catalyst for deeper dialogue and scholarship around the interrelation between domestic abuse and health. That is our collective hope.'
Mithail Afrige Chowdhury was awarded the Striking Solo Photography prize for Urban Travel , a deceptively gentle image of a mother and daughter on a rooftop picnic in Dhaka. With few parks left in the city due to rapid urbanisation, this staged moment, a simple attempt to give a child a taste of nature, becomes an act of resilience. Nearly half of Dhaka's population today are climate migrants, displaced by increasingly extreme weather, and Chowdhury's work highlights the everyday consequences of these shifts: the loss of green space, of childhood rituals, of breath. The photograph is tender, composed, and yet filled with tension, a portrait of care and adaptation under invisible pressures.
Mithail Afrige Chowdhury says, ' When I got the news, the first thing I did was charge my camera—not to take a photo, but to restart something I thought I'd lost. I won't dwell on personal or professional hardships, but this moment means more than I can say. I made this image two years ago, as part of a major project on climate change, urban sustainability, and public health. Then life intervened, and fear slowly pulled me away from the work I loved. But now, I can wake up with an objective. Because someone has my back. And that makes all the difference. Awards can feel technical but this recognition from Wellcome feels deeply human.'
The winner of The Marvels of Scientific and Medical Imaging was announced as Steve Gschmeissner, whose electron microscopy image Cholesterol in the Liver reveals cholesterol crystals (shown in blue) forming inside lipid-laden liver cells (purple). These microscopic shifts, invisible to the naked eye, can have deadly consequences: when cholesterol hardens from liquid to crystal, it damages blood vessels and contributes to heart disease and strokes. Gschmeissner's colourised SEM image transforms this biological process into something visually striking, part data, part artwork. With a career spanning over four decades, and more than 10,000 images published in scientific journals, stamp collections, fashion collaborations, and music albums, his work exemplifies how imaging can bridge science and culture.
Steve Gschmeissner says, ' When I discovered that Wellcome had reintroduced the Marvels of Scientific and Medical Imaging category, I was delighted to enter such a prestigious competition. I was thrilled to be shortlisted, and winning first prize is undoubtedly one of the highlights of my 50-year career of trying to bring the wonders of the microscopic world to all.'
This year's prize drew submissions from over 100 countries. The Top 25 entries featured over 30 individuals from 18 countries, spanning Bangladesh, Brazil, France, Germany, Greece, India, Italy, Myanmar, Peru, South Africa, Spain, Uganda, the UK, USA and beyond.
The winners were selected by an international judging panel comprising leading voices from photography, science, health and journalism. The panel was chaired by Melanie Keen, Director of Wellcome Collection, and included Caroline Hunter, Picture Editor at The Guardian ; Daniella Zalcman, Photographer and Founder of Women Photograph; Benjamin Ryan, Independent Science Journalist; Elizabeth Wathuti, Environmental and Climate Activist; Esmita Charani, Associate Professor at the University of Cape Town; Helen Fisher, Professor of Developmental Psychopathology at King's College London; Noah Green, Science Educator at the Beautiful Biology Initiative; and Mark Lythgoe, Director of the UCL Centre for Advanced Biomedical Imaging.
Wellcome Photography Prize Exhibition
Curated by Laurie Britton Newell and Ligaya Salazar, the Wellcome Photography Prize exhibition features images that reflect a wide spectrum of health experiences, from everyday routines to global challenges. Using techniques such as portraiture, cyanotypes, drone photography, and light and electron microscopy, the image makers show how health is lived, documented and researched around the world.
Many of the works respond to Wellcome's core focus areas, mental health, climate and health, infectious disease and discovery research. Together, they reveal how these issues overlap and take shape in different cultural and geographic contexts. The result is a layered and often unexpected portrait of health today, told through voices and perspectives that are frequently overlooked.
Among this year's highlights are Marks of Majesty: Vanessa by Julia Comita and Stephanie Francis, a portrait honouring the life and choices of a person impacted by breast cancer who opted for aesthetic flat closure, challenging assumptions around gender, illness and identity. Beautiful Disaster by Alexandru Radu Popescu shows a lake of toxic mining waste in Romania that continues to expand each year, an image of both striking beauty and environmental damage. Resilience Artist by Pyaephyo Thetpaing captures a craftsman in Myanmar who creates lacquerware using his foot, offering a broader reflection on health, disability and the role of cultural tradition in healing.
In the scientific imaging category, Ice and Fire Chronics by Ingrid Augusto, Kildare Rocha de Miranda and Vânia da Silva Vieira shows the structure of the parasite that causes Chagas disease, which affects millions across the Americas. Blooming Barrier by Lucy Holland presents goblet cells inside the gut of a child with Hirschsprung's disease, offering insight into how cell structures influence lifelong digestive health. From Butterflies to Humans by Amaia Alcalde Anton reveals the brain of a butterfly mid-metamorphosis, part of a study into neurogenesis with implications for human brain development.
In addition to the Top 25 entries, the exhibition also features Things We Left Unseen , a youth-led photography project developed by Cape Town-based public health organisation Eh!woza. Created in collaboration with young people in the township of Khayelitsha, the project explores health, stigma, and daily life through the eyes of a generation growing up with high HIV and TB burdens, but also with hope and agency.
The exhibition is hosted at the Francis Crick Institute, reflecting a shared commitment to making science more visible through culture.
Ali Bailey, Director of Communications and Public Engagement at the Francis Crick Institute, said: ' We are delighted to host the top images from the Wellcome Photography Prize, showcasing the power of visual storytelling in health and science. The images explore a number of themes that resonate with Crick research, from the health effects of air pollution to neurogenesis. We hope visitors will be moved by the stories behind these incredible photos and also inspired by how beautiful science can be.'
Notes to Editors:
Media Contacts
Sophie Balfour-LynnSutton
[email protected]
Mary-Kate FindonWellcome
[email protected]
Winners' Biographies
Sujata Setia (Storytelling Series)
Sujata Setia is an Indian-born, UK-based artist who's socially engaged, research-led practice combines photography with traditional artistic interventions to explore subaltern histories, cultural imperialism, and the politics of representation. With a background in journalism and a Master's in International Relations from King's College London, her work draws on academic research and community collaboration to centre marginalised voices, particularly through a feminist lens.
Her acclaimed series Changing the Conversation marked a shift away from her earlier portraiture, interrogating the cultural and political construction of beauty. In 2024, she was awarded the Culture King's Grant to develop a lens-based, interdisciplinary project exploring the role of workplace structures for embroidery women artisans in Kashmir. She also recently received the Centre for British Photography Realisation Grant to further expand the scope of A Thousand Cuts , a powerful body of work amplifying the voices of survivors of gender-based abuse.
Setia's work has received major international recognition, including the Sony World Photography Award (Creative category, 2024), LensCulture Critics' Choice Award (2024), Prix Pictet nomination (2023), BJP Female in Focus (2022), and Photographer of the Year at the Tokyo International Foto Awards (2021). Her photography has been exhibited widely—from Somerset House in London to Times Square in New York—and featured in leading publications including The Guardian , CNN , BBC , and Forbes .
Beyond her visual practice, Setia contributes to education and advocacy through teaching ethical storytelling and photography at EFTI in Madrid, and through collaborations with organisations such as SHEWISE and WERESTART in the UK. Her work consistently seeks to reshape public narratives around identity, power, and care through interdisciplinary, justice-focused art.
Mithail Afrige Chowdhury (Striking Solo Photography)
Mithail Afrige Chowdhury is a documentary and street photographer based in Dhaka, Bangladesh. Raised in the city of Khulna, his photography is deeply rooted in the lives of ordinary people. 'Since then, I have always tried to understand people's lives—their pain, joy, and the complexities shaped by social, economic, political, and environmental changes.'
He began photography in 2015 and chose to document what he knew best: life around him. His work has captured the Rohingya refugee crisis , the effects of climate change on Bangladesh (an ongoing project), major festivals, urban water crises, slum fires, and the Covid-19 pandemic.
Mithail has won numerous international photography awards, including the Life Press Photo Award (Ukraine), Xposure International Photography Competition (UAE), Compass Photo Competition by the University of Oxford (UK), and contests in China. His work has been featured in The Guardian , The Daily Sun , The Times of India , Global Photography , and publications from the University of Oxford , ASCE , and Saturday Magazine .
Steve Gschmeissner (The Marvels of Medical and Scientific Imaging)
Steve Gschmeissner is a UK-based photographer and electron microscopy specialist whose career spans over four decades in scientific imaging. After earning a degree in Zoology, he spent 25 years at the Royal College of Surgeons, eventually leading the electron microscopy services, followed by 15 years leading the EM unit at Cancer Research UK.
In 2002, Gschmeissner retired early to dedicate himself to freelance photography, specialising in Scanning Electron Microscopy (SEM). Over the past two decades, he has built an archive of more than 10,000 images, widely published across scientific, medical, and popular media. His work has featured in everything from textbooks and advertising to art, fashion, and music, appearing on album covers for Peter Gabriel, artworks by Damien Hirst, on US Postal Service stamps, and as visual inspiration for an Iris van Herpen's fashion collection.
In 2021, he was awarded the Lennart Nilsson Award for his lifelong contribution to microscopy. His images continue to bridge the worlds of science and visual culture, offering new ways of seeing the invisible.
Full list of Finalists – Top 25 Entries
Striking solo photography Searching for Life – Sandipani Chattopadhyay (India)
Urban Travel – Mithail Afrige Chowdhury (Bangladesh)
Marks of Majesty: Vanessa – Julia Comita & Stephanie Francis (USA)
Musa – Marijn Fidder (Uganda/Netherlands)
The Light Will Come – Dora Grivopoulou (Greece)
Cricket is My Emotion – Ziaul Huque (Bangladesh)
Pie-by-Sam – Reatile Moalusi (South Africa)
Beautiful Disaster – Alexandru Radu Popescu (Romania)
Resilience Artist – Pyaephyo Thetpaing (Myanmar)
Stereo EEG Self-Portrait – Muir Vidler (UK)
Transparent Curtains – Oded Wagenstein (Israel)
Self, Five Years On – Georgie Wileman (UK)
A storytelling series The Loss Mother's Stone – Nancy Borowick (US Virgin Islands)
A Dream to Cure Water – Ciril Jazbec (UK)
Nemo's Garden – Giacomo d'Orlando (Italy)
A Thousand Cuts – Sujata Setia (UK)
I Spend 150 Hours Alone Each Week – Madeleine Waller (Australia/UK)
The marvels of scientific and medical imaging From Butterflies to Humans – Amaia Alcalde Anton (UK)
Ice and Fire Chronics: The Chagas Disease Invader – Ingrid Augusto, Kildare Rocha de Miranda & Vânia da Silva Vieira (Brazil)
Cholesterol in the Liver – Steve Gschmeissner (UK)
Blooming Barrier – Lucy Holland (UK)
Submarine Fever – Jander Matos & Joaquim Nascimento (Brazil)
Organoids – Oliver Meckes & Nicole Ottawa, Eye of Science (Germany)
I've Got You, Under My Skin: Microplastics in Mammalian Tissue – P. Stephen Patrick & Olumide Ogunlade (UK)
Brixton Road, Lambeth – Marina Vitaglione (France/UK)
Exhibition Details
Wellcome Photography Prize 2025 exhibition is curated by Laurie Britton Newell and Ligaya SalazarAt the Francis Crick Institute, 1 Midland Road, London, NW1 1AT17 July – 18 October 2025Open Wednesdays to Saturdays, 10am-4pm (Wednesdays until 8pm)
Admission free
https://wellcome.org/engagement-and-advocacy/engaging-people/wellcome-photography-prize/2025/exhibition
About Wellcome
Wellcome supports science to solve the urgent health challenges facing everyone. We support discovery research into life, health and wellbeing, and we're taking on three worldwide health challenges: mental health, infectious disease and climate and health.
www.wellcome.org
Follow the prize:
Instagram: @wellcomephotoprize
Wellcome Photography Prize 2025 | Wellcome
About the Francis Crick Institute
We are delighted that the Crick are hosting this year's Wellcome Photography Prize exhibition.
The Francis Crick Institute is a biomedical discovery institute with the mission of understanding the fundamental biology underlying health and disease. Its work helps improve our understanding of why disease develops which promotes discoveries into new ways to prevent, diagnose and treat disease.
An independent organisation, its founding partners are the Medical Research Council (MRC), Cancer Research UK, Wellcome, UCL (University College London), Imperial College London and King's College London.
The Crick was formed in 2015, and in 2016 it moved into a brand new state-of-the-art building in central London which brings together 1500 scientists and support staff working collaboratively across disciplines, making it the biggest biomedical research facility under a single roof in Europe.
crick.ac.uk/
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/0d100975-adc1-4f3f-932e-2b3413e62b87
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Ahmedabad Plane Crash
GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


USA Today
22 minutes ago
- USA Today
Trump, tech giants want to make it easier to share health records: What it means for you
President Donald Trump and his top health officials are pursuing a new initiative that will allow people to share their personal health and medical records with doctors and hospitals. Technology giants Apple, Amazon, Google and Open AI as well as health industries companies UnitedHealth Group and CVS Health are among more than 60 companies that have agreed to develop standards to share health information across computer systems. Trump touted the idea of eliminating redundancies such as filling out paperwork at multiple health providers offices. "This will allow patients to easily transmit information from one doctor to another," Trump said during a July 30 briefing with Health and Human Services Secretary Robert F. Kennedy Jr. and Centers for Medicare & Medicaid Services Administrator Mehmet Oz. Trump emphasized the initiative will be voluntary and require patients to opt in. He added there will be no centralized, government-run database storing patients' personal records. "People are very concerned about the personal records," Trump said. "That's their choice ... it will be absolutely quiet." Large hospital systems and some doctors allow patients to share health information, fill out forms and schedule appointments through websites and mobile apps. And health tech companies have developed apps that allow people to track their health information, but these apps often can't access medical records from health providers, said Amy Gleason, acting administrator of the Department of Government Efficiency, or DOGE. Companies operating 21 networks have agreed to an "interoperability framework" to meet Centers for Medicare & Medicaid Services criteria, according to the Trump administration. Hospital systems and electronic health records vendors have agreed to cooperate in the effort, according to CMS. Participating apps would help people manage obesity and diabetes, including the use of AI assistants to help check symptoms or schedule appointments, CMS said. Privacy, data security remain top worries The health care industry and tech companies have been attempting to reduce paperwork and seamlessly share electronic health records for three decades, said Chris Pierson, CEO of BlackCloak, an Orlando, Florida-based cybersecurity company. Hospitals, doctors, labs and vendors that directly handle such sensitive medical records are subject to a federal privacy law, called the Health Insurance Portability and Accountability Act, or HIPAA. To make health information and records more portable and accessible, consumers need to be guaranteed strong privacy protections and granted control over what information is shared, Pierson said. A consumer might be willing to share their sensitive information with doctors, hospitals or labs. But the same person might want to block an app from sharing records with third parties such as exercise equipment vendors or nutritional supplement retailers. Pierson said such apps would likely still need to comply with HIPAA and other federal and state laws. Given that the apps are voluntary and require consent, they likely would comply with privacy laws, Pierson said. Companies also would need to safeguard information technology security to protect the sensitive information from data breaches. Hackers target health records Digital medical records are a popular target for hackers seeking sensitive health information, bank records and a person's identifiable information such as dates of birth and Social Security numbers. The number of attacks has surged in recent years and are often carried out by organized hackers, often operating overseas, who target the computer systems of health providers and the vendors and companies that serve them. HHS investigates whether breaches involve violations of health information privacy and security laws and publicly reports attacks that affect 500 or more on its website. In July alone, more than two dozen data breaches compromised the records of more than 3 million people, HHS records show. The largest hack in recent years involved the February 2024 attack on UnitedHealth-owned subsidiary Change Healthcare. The attack disrupted the health care industry because doctors and hospitals were unable to collect payments for weeks when computer systems went down.
Yahoo
2 hours ago
- Yahoo
Knight Therapeutics Announces Regulatory Supplemental Submission of MINJUVI® (tafasitamab) for Follicular Lymphoma in Brazil
MONTREAL, July 31, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, United Medical Ltda., has submitted a supplemental application to ANVISA, the Brazilian health regulatory agency, seeking approval for an additional indication for MINJUVI® (tafasitamab) in combination with rituximab and lenalidomide for the treatment of adult patients with previously treated follicular lymphoma (FL). The supplemental application for the additional indication was selected for review under Project Orbis. In September 2021, Knight entered into an exclusive supply and distribution agreement with Incyte (NASDAQ:INCY), for the exclusive rights to distribute tafasitamab (sold as MONJUVI® in the United States and MINJUVI® outside of the U.S.), as well as PEMAZYRE® (pemigatinib), in Latin America. In February 2024, Knight announced the launch of MINJUVI® in Brazil in combination with lenalidomide followed by MINJUVI® monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), including DLBCL arising from low grade lymphoma, and who are not eligible for autologous stem cell transplant (ASCT). 'This regulatory submission for a new indication for tafasitamab in relapsed or refractory FL highlights our steadfast commitment to bringing innovation and enhancing quality of life and care,' said Samira Sakhia, President and Chief Executive Officer of Knight Therapeutics. 'If approved, the combination of tafasitamab, rituximab and lenalidomide will be an important new therapeutic option for eligible adult patients with previously treated FL in Brazil. We look forward to continuing to work towards regulatory submissions in additional countries in Latin America over the next months.' About Follicular Lymphoma (FL) and inMIND Study FL is the most common indolent, or slow growing, form of non-Hodgkin lymphoma (NHL).1 In Brazil, according to the 2023 data from the National Cancer Institute (INCA) Registries, the expected incidence/year of NHL (inclusive of all subtypes) was 5.57 per 100, 000 in the general population, 6.42 per 100,000 in the male population, and 5.62 per 100,000 in the female population. It is expected that follicular lymphoma constitutes 20% to 25% of adult NHL cases.2,3,4 There are limited treatment options for relapsed or refractory FL.5 The submission is based on the results from the pivotal Phase 3 inMIND trial, a double-blind, placebo-controlled trial randomizing 548 patients with relapsed or refractory FL to receive tafasitamab or placebo with lenalidomide and rituximab. Key results from the trial demonstrated that tafasitamab plus lenalidomide and rituximab significantly improved progression-free survival (PFS) in patients with relapsed or refractory FL compared to a placebo. The median PFS was 22.4 months in the treatment arm versus 13.9 months in the placebo arm, representing a 57% reduction in the risk of disease progression, relapse, or death. Secondary endpoints also showed improvements, with higher response rates and longer durations of response observed in the treatment arm.6 About MINJUVI® (tafasitamab)MINJUVI® (tafasitamab) is a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody. Tafasitamab incorporates an XmAb® engineered Fc domain, which mediates B-cell lysis through apoptosis and immune effector mechanism including Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) and Antibody-Dependent Cellular Phagocytosis (ADCP). Incyte licenses exclusive worldwide rights to develop and commercialize tafasitamab from Xencor, Inc. In the U.S., MONJUVI® (tafasitamab-cxix) is approved by the U.S. Food and Drug Administration in combination with lenalidomide and rituximab for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL). MONJUVI® is not indicated and is not recommended for the treatment of patients with relapsed or refractory marginal zone lymphoma outside of controlled clinical trials. Additionally, MONJUVI® received accelerated approval in the United States in combination with lenalidomide for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) not otherwise specified, including DLBCL arising from low grade lymphoma, and who are not eligible for autologous stem cell transplant (ASCT). In Europe, MINJUVI® (tafasitamab) received conditional Marketing Authorization from the European Medicines Agency in combination with lenalidomide, followed by MINJUVI® monotherapy, for the treatment of adult patients with relapsed or refractory DLBCL who are not eligible for ASCT. XmAb® is a registered trademark of Xencor, Inc. MONJUVI, MINJUVI, the MINJUVI and MONJUVI logos and the 'triangle' design are registered trademarks of Incyte. About Knight Therapeutics Inc. Knight Therapeutics Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing and commercializing pharmaceutical products for Canada and Latin America. Knight's Latin American subsidiaries operate under United Medical, Biotoscana Farma and Laboratorio LKM. Knight Therapeutics Inc.'s shares trade on TSX under the symbol GUD. For more information about Knight Therapeutics Inc., please visit the company's web site at or Forward-Looking Statements This document contains forward-looking statements for Knight Therapeutics Inc. and its subsidiaries. These forward-looking statements, by their nature, necessarily involve risks and uncertainties that could cause actual results to differ materially from those contemplated by the forward-looking statements. Knight Therapeutics Inc. considers the assumptions on which these forward-looking statements are based to be reasonable at the time they were prepared but cautions the reader that these assumptions regarding future events, many of which are beyond the control of Knight Therapeutics Inc. and its subsidiaries, may ultimately prove to be incorrect. Factors and risks which could cause actual results to differ materially from current expectations are discussed in Knight Therapeutics Inc.'s Annual Report and in Knight Therapeutics Inc.'s Annual Information Form for the year ended December 31, 2024, as filed on Knight Therapeutics Inc. disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information or future events, except as required by law. References: Kaseb H, et al. Follicular Lymphoma. Treasure Island (FL): StatPearls Publishing; 2025 Jan. Kanters S, et al. BMC Cancer. 2023;23:74. Smith SM, Salles G. Haematologica. 2022;107:4-6. Swerdlow SH, Campo E, Pileri SA, et al. Blood. 2016;127:2375-2390. Decision Resources Group. Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia, Landscape & Forecast. 2020. Sehn L H., et al. ASH Annual Meeting 2024; Late Breaking Abstract Tafasitamab Plus Lenalidomide and Rituximab for Relapsed or Refractory Follicular Lymphoma: Results from a Phase 3 Study (inMIND). Investor Contact: Knight Therapeutics Inc. Samira Sakhia Arvind Utchanah President & Chief Executive Officer Chief Financial Officer T: 514.484.4483 T. +598.2626.2344 F: 514.481.4116 Email: IR@ Email: IR@ Website: Website: in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
Bare hands on food: San Angelo weekly restaurant inspections
The San Angelo/Tom Green County Health Department regularly monitors restaurants and food establishments for compliance with state food safety requirements. Frequent inspections are essential in preventing the spread of foodborne illnesses through contamination and improper handling, storage and sanitation. Scores for retail food establishments, food stores, mobile food units and school and daycare establishments inspected the week of July 13-19 are listed below. The Standard-Times obtained the information through an open records request. Disclaimer: On any given day, an establishment may have fewer or more violations than noted in its most recent inspection. An inspection conducted on any given day may not be representative of the overall, long-term conditions at the establishment. A few more recent, follow-up inspections may not be included here. Environmental Health Division inspectors fill out one page of these reports. Other Texas health divisions, such as in Taylor and Wichita counties, fill out multiple pages with details, providing more information the public can obtain about local establishments that handle food. Any issues, comments or corrections are verbalized to local restaurants, according to Sandra Villarreal, the San Angelo-based health services director. All food establishments are inspected in accordance with the Texas Food Establishment Rules as adopted by the city of San Angelo. Perfect scores CVS Pharmacy, 4210 S. College Hills Dollar General, 3515 Lutheran Way Food Mart #7, 1801 S. College Hills Blvd. Ichiban Japanese Steak House (kitchen, bar, sushi bar), 2412 S. College Hills Blvd. Jason's Deli, 1819 Knickerbocker Road Nana's Sweet Shop, 3228 S. College Hills Blvd. Peasant Village, 23 S. Park St. Smoothie King, 1819 Knickerbocker Road St. Paul Presbyterian Church, 11 N. Park St. Taco Bell, 1701 Knickerbocker Road The Penny Bar & Grill, 2412 S. College Hills Blvd. Twin Peaks (bar 1 and 2), 1601 Knickerbocker Road Walmart (grocery, produce), 5154 Knickerbocker Road High to moderate scores Angoria, 402 W. Beauregard Ave.: 95 Cold Smoke Craft House, 1819 Knickerbocker Road: 95 Fleming's Family Diner, 2105 Knickerbocker Road: 99 Jack and Jill Donut, 4113 S. College Hills Blvd.: 99 Kountry Tyme Academy, 3866 W. Houston Harte: 98 La Mexicana Tortilleria, 2719 N. Chadbourne St.: 98 Little Angels Restaurant (Taqueria Lupita Mobile), 602 Pulliam St.: 92 Los Gallos Bakery, 2029 Armstrong St.: 93 Pizza Hut, 1606 Pulliam St.: 97 Starbucks, 401 W. 3rd St.: 98 Stockman's Restaurant, 1131 N. Bell St.: 94 Taco Bueno, 330 W. 9th St.: 98 Twin Peaks (kitchen), 1601 Knickerbocker Road: 96 Urban Salt (kitchen), 23 W. Beauregard Ave.: 94 Urban Salt (bar), 23 W. Beauregard Ave.: 92 Vasquez, 2901 N. Chadbourne St.: 94 Vasquez (deli), 2901 N. Chadbourne St.: 93 Vasquez (mobile), 2901 N. Chadbourne St.: 99 Walmart (bakery), 5154 Knickerbocker Road: 93 Walmart (deli), 5154 Knickerbocker Road: 94 Low scores and why El Paisano #3, 2902 Sherwood Way: 70 Out of compliance: Food products not covered (repeat offense) Food not stored 6 inches off floor (repeat offense) Not washing hands (repeat offense) Bare hands on food (repeat offense) Toxic substances not identified (repeat offense) No certified food manager on site No proper marking date on food (repeat offense) No thermal test strips Handwashing facilities not used (repeat offense) Dirty cooler doors Nonfood contact surfaces not clean Little Caesars, 1821 Knickerbocker Road: 72 Out of compliance: Food not in safe condition Hands not washed properly No certified food manager present (repeat offense) No proper marking date on food Food permit not posted No thermal test strips (repeat offense) No adequate ventilation (repeat offense) Physical facilities and toilet facilities not maintained, clean (repeat offense) Mesquite Bean, 36 E. Twohig Ave.: 84 Out of compliance: Food not in safe condition Toxic substances not identified No certified food manager present No proper marking date on food No adequate ventilation Nonfood contact surfaces not clean Physical facilities not clean For more information on Environmental Health's services or to file a complaint against a food establishment or report another public health nuisance, call 325-657-4493. June 29-July 5 Toxic substances not identified: San Angelo weekly restaurant inspections June 22-28 Insect/rodent contamination: San Angelo weekly restaurant inspections This article originally appeared on San Angelo Standard-Times: See how San Angelo eateries did in latest restaurant inspections Solve the daily Crossword